DAILY UPDATE
 December 22, 2021
Dear Valued Reader,

We've been seeing pitches about the promise of space for a couple years now, and mostly the usual suspects in space tourism or space-based internet access have been the targets... but Jason Simpkins at the Outsider Club is teasing a stock I haven't written about before, so I thought we'd follow up on his "IPO Opportunity of the Decade" today... worth a buy?  Just click below to...


Are you ready for the EV revolution?

Well, today you have the chance to get the names of 8 EV stocks, handpicked by an analyst who has beaten Warren Buffett over a 15-year period.

Louis Navellier found Apple at $1.49... Oracle at 51 cents... and Microsoft at 38 cents...

Now he's named 8 of his favorite EV plays in a free report.

Just click here to claim your copy.


Advertisement

It seems a little cruel to talk up the obesity epidemic when we're smack-dab in the middle of the "overeating" part of the calendar... but Dave Lashmet at Stansberry is teasing a coming approval for an amazingly effective obesity drug as likely to create the "biggest drug in the world", maybe generating more than a trillion dollars in sales.  So what's the story, and what's the stock?  Just click below to...



Stock Gumshoe | travis@stockgumshoe.com | www.stockgumshoe.com
351 Pleasant St., Suite B #205, Northampton, MA 01060
Disclaimer: Nothing in this email or in the linked articles should be considered to be individual investment advice -- we can't tell you what you should do with your money, we can just share our opinions and perspective. Our authors try to use reliable information sources but also make mistakes of both fact and judgement on occasion, so all assertions should be checked and confirmed. You should speak with your financial advisor and understand everything fully before committing money to any investment.

Most issues of this email newsletter include advertising, and it should not be assumed that the presence of an advertisement means that the product or service advertised is endorsed by Stock Gumshoe or the author. For full disclaimers, disclosure information, and privacy policies please see the prominent links at the bottom of each page at StockGumshoe.com.

Having trouble viewing this email? Read the web version.

You may unsubscribe if you no longer wish to receive our emails. We have no wish to email people who don't want to receive these messages. Please note that unsubscribing applies only to receiving emails, if you are a member of the Stock Gumshoe Irregulars that membership will not automatically change or be canceled. Please contact us if you need to change a paid membership.